STAT Plus: You have questions on CRISPR. We have answers
JUSTIN SULLIVAN/GETTY IMAGES
Is insurance going to cover CRISPR therapies? What are the anticipated safety risks? And how is the viral vector industry developing?
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario